Mindray Medical (MR - option chain) shares are rising today after the Chinese medical devices company announced preliminary 2010 results, saying it now expects fiscal-2010 revenues to come in at $703 million, up from a previous forecast of $700 million. Analysts have forecast 2010 revenue of $703.56 million. If you think that the stock won't fall by too much in the coming months, then now could be a good time to look at a bullish hedged trade on MR.

MR opened this morning at $28.05. So far today the stock has hit a low of $28.02 and a high of $29.04. As of 12:15, MR is trading at $28.25 up $1.20 (4.4%). The chart for MR looks neutral and S&P gives MR a neutral 3 STARS (out of 5) hold ranking.

"We believe many outstanding buying opportunities are available among these undervalued foreign stocks; we screened the Zacks, Investors Business Daily, S&P and Value Line databases to find foreign companies with rapidly growing earnings," says J. Royden Ward.

The editor of Cabot Benjamin Graham Value Letter explains, "We believe these six companies offer excellent appreciation potential at reasonable prices: Lululemon Athletica (LULU), Mindray Medical (MR), Potash (POT), Seagate Technology (STX), Silver Wheaton (SLW) and Telefonica SA (TEF)."

This post is part of a special report, Top Picks for 2010, the 27th annual survey in which TheStockAdvisors.com asks the nation's leading advisors for their single favorite stock for the new year. See all 80 stocks listed here.

"Mindray Medical International Limited (MR), a China-based medical devices firm, is our top investment idea for the coming year," says Alan Newman.

In his CrossCurrents newsletter, he notes, "The company is headquartered in Shenzhen, China, and is one of many Chinese companies now specializing in the development, manufacture and marketing of medical devices worldwide.

Those surprised by the market's strength in recent weeks should be even more impressed with the rebound in China, where both their market and economy have proven among the most resilient in the world.

Global specialist Nicholas Vardy adds, "While the US markets are rising, Asian stocks are on fire." ETF expert Paul Tracy adds, "China funds have screamed to the top of the performance charts."

In large part, this strength is due to the country's stimulus program. Tracy points out, "To combat the sagging global economy, Chinese Premier Wen Jiabao orchestrated a massive 4 trillion yuan ($586 billion) stimulus package.